Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
Summary: The Plasmodium vivax lifecycle encompasses a dormant liver-stage known as 'hypnozoite’ which serves as silent reservoirs of malaria, reactivation of which results in recurring episodes of relapse with varying periodicity. This contributes to continuous transmission of malaria unamenabl...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-06-01
|
| Series: | The Lancet Regional Health - Southeast Asia |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772368223000598 |
| _version_ | 1797846233000181760 |
|---|---|
| author | Manju Rahi Preeti Rana Sirohi Amit Sharma |
| author_facet | Manju Rahi Preeti Rana Sirohi Amit Sharma |
| author_sort | Manju Rahi |
| collection | DOAJ |
| description | Summary: The Plasmodium vivax lifecycle encompasses a dormant liver-stage known as 'hypnozoite’ which serves as silent reservoirs of malaria, reactivation of which results in recurring episodes of relapse with varying periodicity. This contributes to continuous transmission of malaria unamenable to control methods. The prevention of relapse requires a “radical cure” by a hypnozoitcidal drug. Primaquine (PQ) has been the recommended radical cure for this malaria. However, adherence to 14 days PQ treatment remains poor. India accounts for majority of P. vivax burden globally. However, PQ administration is not supervised in the current national programme. Supervised administration of drugs ensures compliance and improves drug regime success rate. Trials across different countries have established the effectiveness of directly observed therapy (DOT) for prevention of relapses. As India aims to eliminate malaria by 2030, it is prudent to consider DOT to ensure complete treatment of the malaria affected populations. Therefore, we recommend that the Indian malaria control programme may consider DOT of primaquine for treatment of vivax malaria. The supervised administration would entail additional direct and indirect costs but will ensure complete treatment and hence minimize the probability of relapses. This will help the country in achieving the goal of malaria elimination. |
| first_indexed | 2024-04-09T17:51:39Z |
| format | Article |
| id | doaj.art-9005be8c6f694e4b94331287f6990db0 |
| institution | Directory Open Access Journal |
| issn | 2772-3682 |
| language | English |
| last_indexed | 2024-04-09T17:51:39Z |
| publishDate | 2023-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Lancet Regional Health - Southeast Asia |
| spelling | doaj.art-9005be8c6f694e4b94331287f6990db02023-04-16T04:12:33ZengElsevierThe Lancet Regional Health - Southeast Asia2772-36822023-06-0113100199Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in IndiaManju Rahi0Preeti Rana Sirohi1Amit Sharma2Indian Council of Medical Research, New Delhi, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India; Corresponding author. Indian Council of Medical Research, New Delhi, India.Indian Council of Medical Research, New Delhi, IndiaAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India; International Centre for Genetic Engineering and Biotechnology, New Delhi, IndiaSummary: The Plasmodium vivax lifecycle encompasses a dormant liver-stage known as 'hypnozoite’ which serves as silent reservoirs of malaria, reactivation of which results in recurring episodes of relapse with varying periodicity. This contributes to continuous transmission of malaria unamenable to control methods. The prevention of relapse requires a “radical cure” by a hypnozoitcidal drug. Primaquine (PQ) has been the recommended radical cure for this malaria. However, adherence to 14 days PQ treatment remains poor. India accounts for majority of P. vivax burden globally. However, PQ administration is not supervised in the current national programme. Supervised administration of drugs ensures compliance and improves drug regime success rate. Trials across different countries have established the effectiveness of directly observed therapy (DOT) for prevention of relapses. As India aims to eliminate malaria by 2030, it is prudent to consider DOT to ensure complete treatment of the malaria affected populations. Therefore, we recommend that the Indian malaria control programme may consider DOT of primaquine for treatment of vivax malaria. The supervised administration would entail additional direct and indirect costs but will ensure complete treatment and hence minimize the probability of relapses. This will help the country in achieving the goal of malaria elimination.http://www.sciencedirect.com/science/article/pii/S2772368223000598MalariaPlasmodium vivaxPrimaquineDirectly observed therapy |
| spellingShingle | Manju Rahi Preeti Rana Sirohi Amit Sharma Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India The Lancet Regional Health - Southeast Asia Malaria Plasmodium vivax Primaquine Directly observed therapy |
| title | Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India |
| title_full | Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India |
| title_fullStr | Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India |
| title_full_unstemmed | Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India |
| title_short | Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India |
| title_sort | supervised administration of primaquine may enhance adherence to radical cure for p vivax malaria in india |
| topic | Malaria Plasmodium vivax Primaquine Directly observed therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2772368223000598 |
| work_keys_str_mv | AT manjurahi supervisedadministrationofprimaquinemayenhanceadherencetoradicalcureforpvivaxmalariainindia AT preetiranasirohi supervisedadministrationofprimaquinemayenhanceadherencetoradicalcureforpvivaxmalariainindia AT amitsharma supervisedadministrationofprimaquinemayenhanceadherencetoradicalcureforpvivaxmalariainindia |